Inhibition by lithium and rubidium of gentamicin-induced release of N-acetyl-β-D-glucosaminidase from perfused rat kidney

Add time:07/25/2019    Source:sciencedirect.com

N-acetyl-β-D-glucosaminidase (NAG) is one of the sensitive hydrolytic lysosomal enzymes which is released after renal tubular damages. We studied gentamicin-induced nephrotoxicity by determining the NAG release in perfused rat kidney. 100 μg/ml of gentamicin caused a time-dependent increase in enzymuria, peaking at 90 min. At this time the released NAG is about sixfold more than the control. The effect of concurrent perfusion with 100 μg/ml gentamicin and with 0.5 mmol/l lithium chloride or 0.5 mmol/l rubidium chloride in the perfusion fluid was also studied by measuring NAG activity in the perfusate. Both cations decrease the gentamicin-induced NAG release. However, the inhibitory effect of lithium chloride may be due to interference of this ion with the polyphosphoinositide cycle in renal tubular lysosomal membranes. There is no obvious evidence for an inhibitory effect of rubidium chloride.

We also recommend Trading Suppliers and Manufacturers of RUBIDIUM BICARBONATE (cas 19088-74-5). Pls Click Website Link as below: cas 19088-74-5 suppliers

Prev:Effects of chronic hyperfiltration on proximal tubule bicarbonate transport and cell electrolytes
Next:Raman spectra of potassium carbonate and bicarbonate aqueous fluids at elevated temperatures and pressures: comparison with theoretical simulations)